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ABSTRACT: A large number of anti-cancer chemotherapeutics target DNA topoisomerases. Etoposide is a specific
topoisomerase II poison that causes reversible double strand DNA breaks. This project analyses the repair of DNA
damage induced by etoposide, a common anti-cancer chemotherapeutic. Through the comparison of two known
DNA repair pathways, anti-cancer chemotherapy may become more cytotoxic. Double strand DNA break repair is
mediated by either non-homologous end joining (NHEJ) or homologous recombination (HR). NHEJ repairs through
direct ligation of a double stranded break, whereas HR utilizes a homologous template to recover the wild type
sequence. Reporter cassettes involving the expression of green fluorescent protein were used to distinguish between
these repair mechanisms. Titrations with etoposide show that a logarithmic increase in drug concentration yields a
corresponding increase in repair through HR. This result demonstrates that topoisomerase II mediated damage is
efficiently repaired by the process of HR. Additional experiments with another reporter cassette indicated that repair
of topoisomerase II mediated DNA damage occurs more efficiently through the HR pathway than the NHEJ pathway.
Collectively, the data suggest that tumor cells proficient in HR repair may effectively elude treatment by topoisomerase
II targeting drugs.
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INTRODUCTION
Topoisomerase poisons are widely used as anti-cancer
chemotherapeutics [2]. Topoisomerase IIα (topoIIα) is
the target for many anti-cancer agents because cancer
cells have increased mitotic activity, requiring an increase
in topoIIα expression.

allowing for the increase or decrease in linking number
by one through the pivoting of one phosphodiester
backbone around the other.

Topoisomerase IIa Mechanism
TopoIIα stimulates relaxation, decatanation, and
unwinding DNA during replication and cellular division
(Figure 1). A prime example of topoIIα catalytic activity
is during DNA replication when the replication fork
melts the DNA hydrogen bonds between base pairs. As
a result, the DNA preceding the replication fork begins
to wind into a highly taut coil called a supercoil. If left
alone, this negative supercoiling can be so severe as to
fracture the DNA itself, thereby creating a genotoxic
event [2]. TopoIIα relaxes the supercoiling.
TopoIIα is homodimer with a Mg2+ cation per dimer.
TopoIIα exists as closed or open clamps dependent upon
ATP binding. ATP binding switches topoIIα from an
open to closed clamp formation. In each subunit of
human topoIIα, the Mg2+ cation stabilizes the tyrosine
– 804 residue, thus allowing a nucleophillic attack of the
5’ phosphodiester bond [2]. The mechanism is repeated
on both sides of the double helix. As a result, TopoIIα
becomes covalently bound and creates a protein-DNA
adduct with a double stranded break (DSB). Transient
strand passage translocates the uncut strand through the
DSB. Within the active site, the dissociated ends are
religated. ATP hydrolysis then switches the homodimer
to the open conformation. This mechanism is equilibrated
and can either increase or decrease the linking number
by two, meaning that both phosphodiester backbones are
translocated, tightening or relaxing the helical structure.
The isozyme topoIIβ is not mitotically stimulated and is
poorly understood, but it is known to share this
mechanism [2] (Figure 1).
Topoiomerase I Mechanism
Topoisomerase I (topoI) is relevant to mitotic,
transcription, and promoter regulation [2]. TopoI does
not require ATPase activity. A tyrosine residue performs
a nucleophilic attack on the 5’ phosphodiester bond,
creating a single stranded gap. TopoI transfers the free 3’
end about the intact strand and religates the gap within
the catalytic site. The topoI mechanism is in equilibrium,
https://stars.library.ucf.edu/urj/vol5/iss1/6

Figure 1 - A. Topoisomerase II Poison;
B. Topoisomerase II Enzyme Mechanism [2]
Topoisomerase IIα Poisons
TopoII poisons such as etoposide (VP16) stabilize
enzyme/DNA cleavages and fragment the genome
(Figure 1). Many topoIIα agents are in clinical use and
are approved by the Food and Drug Administration [5].
Therefore, it is vital that an understanding of how
topoIIα breaks are repaired allowing cancer cells to elude
treatment is necessary. VP16 itself is a widely used
chemotherapeutic agent and readily available, thus will
be the focus of this project [5].
Chemotherapy sometimes requires high dosages of
topoIIα agent to ensure that DNA damage does not
undergo repair, as the cleavage complex is a transient and
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reversible event [2]. The stabilized DSB created by
topoIIα poisons increase the half-life of the cleavage
complex. DNA/topoII complexes are processed by the
26S proteosome, a macromolecular structure that
degrades ubiquitinated proteins, thus removing the
topoIIα polypeptide portion and leaving a DSB (Figure
2) [4]. Recent studies indicate that the removal of the
topoIIα protein can be performed through CtIP and the
phosphodiesterases TDP1 and TDP2 [9]. If the DNA
damage is not efficiently repaired, the cell will undergo
apoptosis. This could possibly reduce the amount of
agent needed to fight the malignancy. Information on
the repair process can lead to new strategies that can
inhibit the reversal of topoIIα mediated DNA damage,
thereby minimizing patient side effects through the
increase of drug efficacy.

DSB Repair Pathways
DSBs are common events. The dissociated ends created by
DSBs can reassociate indiscriminately, differing in sequence from
the wild type and thereby creating chromosomal translocations
[7]. To circumvent this, cells evolved two known mechanisms
to correct the DSB: non-homologous end joining (NHEJ) and
homologous recombination (HR).
NHEJ is the main pathway by which healthy cells repair DSBs;
however, this can alter gene regulation or expression (Figure 3).
The process involves the direct ligation of a DSB without regard
to sequence homology or phase of the cell cycle [12]. NHEJ is
a low fidelity, high mutation prone pathway, but repairs DSBs
rapidly [12]. Ku, a heterodimer of Ku70 and Ku80, recognizes
the DSB and initiates the NHEJ repair pathway [12]. The Ku
protein attracts DNA-PKcs by forming a holoenzyme and autophosphorylates itself, possibly providing the energy needed for
the subsequent blunt ligation. NHEJ provides genomic stability
with a half life of 30 minutes [12].
HR is a high fidelity but time-consuming pathway occurring
mainly in the late phases of the cell cycle [1]. HR commences
upon DNA damage recognition, and a cascade of signaling
recruits proteins that further resect the break to single stranded
3’ ends (Figure 3) [8]. The single stranded ends are then coated
with single stranded binding proteins, protecting the templates.
These unbound ends are then wrapped with Rad51, which is associated with BRCA1. With Rad51 bound, the single stranded
DNA participates in homology recognition [1]. The Rad51
complex also allows for strand exchange. Subsequent branch
migration and nucleotide polymerization from DNA polymerase
II occur. The whole complex then resolves itself with an exact
copy of the template homolog where the DSB occurred. Most
non-cancer cells are in the resting phases of the cell cycle and
thus are not subjected to the HR pathway often.
Goal

Figure 2 - TopoII Cleavage Complex Repair [4].

Published by STARS, 2011

This research project analyzes whether topoII/DNA damage
complexes are repaired through either HR or NHEJ. DNA
repair events resulting from poison damage can be quantified
through the use of a highly specific reporter cassette for either
HR or NHEJ. With this experimental system, we found that
HR is the preferred DSB repair pathway in HeLa cells. This
knowledge could lead to increased efficacy of anti-cancer chemotherapeutics by blocking HR pathway proteins and/or signaling.
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Figure 3 - NHEJ [11] and HR [7] Pathways. NHEJ uses the Ku complex to recruit subsequent proteins such as
DNA-PKcs, ultimately resulting in blunt double strand ligation of the DSB. HR is a high fidelity pathway that
uses a donor sequence as a template, thus resulting in high fidelity DNA retrieval.
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METHODS AND MATERIALS
NHEJ and HR Reporter Plasmids
The reporter plasmids for both NHEJ and HR employ
a similar approach. The presence of the restriction
endonuclease ISce-I produces a highly specific DSB
at the designated ISce-I cut site (Figure 4). NHEJ or
HR can then be used to repair the DSB. With HR,
the second cassette has a homologous sequence that allows repair of the DSB, expression of GFP. The NHEJ
reporter plasmid has the ISce-I cut site centrally located
between the GFP sequence, with GFP expression upon
blunt ligation.
Exposure of HR HeLa cells to Etoposide and ISce-I
HR HeLa cells were transfected with pISce-I using
Lipofectamine Reagent 2000 (Invitrogen, Carlsbad,
CA), according to the manufacturer’s instructions. At
24 hours post transfection, the cells were treated with
the desired concentration of VP16 for one hour. Cells
were then incubated for 24 and 72 hours in the absence
of VP16 to establish a time course for recovery. At the
end of each respective recovery incubation time, GFP
fluorescence was read using FACSCalibur Fluorescence
Activated Cell Sorter (FACS) and CellQuest software
(BD Bioscience, San Jose, CA).
Doxycycline inducible ISce-I expression system
The inducible reporter system used for the NHEJ and
HR HeLa cells lines (Figure 4) were stably integrated
by Dr. Bongyong Lee. The RY-HR HeLa cell line
is not doxycycline inducible. These reporters use a
tetracycline induction system to transcribe ISce-I
endonuclease. Doxycycline is a semi-synthetic tetracycline derivative. Following exposure to doxycycline,
the pCMV promoter sequence is exposed, allowing for
transcription of the ISce-I downstream gene. Without
doxycycline exposure, no ISce-I is expressed. Expression
of the ISce-I restriction enzyme creates a DSB at the
ISce-I cut site (Figure 4), thereby allowing the cells to
perform DSB repair.
Analysis of Repair of Topoisomerase I and II DNA Damage
by HR and NHEJ Pathways
Stably integrated RY-HR HeLa cells and inducible,
stably integrated NHEJ HeLa cells were observed to be
in exponential growth. The plates were then exposed to
Published by STARS, 2011

an increase in VP16 concentration, and an increase in
campothecin (CPT), a topoisomerase I poison, for one.
A positive control and a transfection efficiency control
were set up by the transfection of pISce-I and pEGFP
utilizing Lipofectamine 2000 reagent, according to
manufacturer’s instructions. Single plates for both
lines were left untreated and untransfected as a negative control. The plates were then incubated for three
days following the drug treatments. After incubation,
the supernatant of the plates and the trypsinized cells
were transferred to a 15 mL conical tube. The cells were
analyzed via FACSCalibur FACS and CellQuest Pro
(BD Software) for GFP expression.
Screening of RYHR-GFP clones
HeLa cells stably integrated with the RYHR plasmid
(TopoGEN, Daytona Beach, Florida) were provided
by Alex Fagenson (Muller lab, UCF). Colonies were
selected as single clones and were subcultured to expand
the clones. Clone screening was performed by transfecting pISce-I with Lipofectamine Reagent 2000 for
five hours. The cells were then incubated in the absence
of pISce-I for 24, 72, and 144 hours to establish a time
course for recovery. Using the FACSCalibur FACS and
CellQuest software, GFP expression was calculated.
The best clone was kept for further projects, and the
remaining clones were discarded.
Analysis of HR in RY-HR Stably Integrated HeLa Cells
Using VP16
Making sure the cells were in heavy exponential growth,
increasing VP16 concentrations were added and
exposed continuously for five days until 100% confluency. In separate subcultures, a titration of VP16 was
exposed to the cells for one hour. One plate was left
untreated, and the last plate was exposed to five µg of
ISce-I for four hours with Lipofectamine Reagent 2000
according to the manufacturer’s instructions in 5 mL
OPTI-MEM I. The cells were then grown to confluency without any additives. Using the FACSCalibur
and CellQuest software, GFP expression was read.
Trypan Blue Exclusion Assays for Cell Viability
RY-HR HeLa cells and NHEJ HeLa cells were treated
with increasing VP16 concentrations. The cells were exposed to VP16 for one hour. After three days incubation
without VP16, trypan blue dye was aliquot to microcentrifuge tube. The supernatant of each well was saved
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in a 15 mL conical tube. The cells were trypsinized and
added to the supernatant. From the cell suspension, 20
µL was added to the 180 µL of 0.1% trypan blue dye.
From that, 10 µL of the dyed cells were injected into a
hemocytometer slide and viewed under a microscope.
The slide was divided into four quadrants, and each of
the four quadrants was counted and totaled. A ratio
of stained versus unstained cells indicates percentage
cytotoxicity.
Confocal Microscopy
The three lines of HeLa cells were seeded on a cover
slip. ISce-I was transfected using Lipofectamine
Reagent 2000 for the non-inducible RYHR clone was
added, according to manufacturer’s instructions, for four
hours, and doxycycline was added to the media for the
inducible systems. One hour drug treatments of VP16
were then performed at varying concentrations. Following drug treatment, the cells were incubated for 24
and 48 hours without pISce-I or doxycycline exposure
to establish a time course. Using a bent hypodermic
needle, the cover slips were carefully removed. A 1.5
µM PI staining solution stained the cells for thirty
minutes in the dark. Using FischerFinest Premium
Slides, one drop of emulsion oil was placed between the
slide and the cover slip. Clear nail polish was then used
to seal the cover slip to the slide. Following drying, the
slides were analyzed using a confocal microscope at 20X
and 100X power.

https://stars.library.ucf.edu/urj/vol5/iss1/6
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B

Figure 4 – The RY-HR and NHEJ Reporter Constructs.
(A): RY-HR reporter system. The RY element and the ISce-I loci create DSBs when exposed to a topoIIα poison or ISce-I restriction endonuclease respectively. Following a DSB, cassette I searches for homology amongst
cassette II, leading to HR repair of the DSB and GFP expression. Before HR repair, cassettes 1 and II are incapable of expressing GFP due to mutations in the first cassette and a stop codon in the second cassette. Following
HR repair as indicated by the diagram, cassette I can express GFP.
(B): The NHEJ reporter system. The opposing ISce-I restriction cut sites allow for direct ligation of the opposing cassettes initiating GFP expression. The RY sequence is not needed due to the size of the NHEJ reporter
system. The RY-HR reporter cassette is substantially smaller than the NHEJ reporter cassette, thus a targeting
agent is needed to initiate HR using a topoIIα poison.

Published by STARS, 2011

www.URJ.ucf.edu

57

7

The Pegasus Review: UCF Undergraduate Research Journal (URJ), Vol. 5 [2011], Iss. 1, Art. 6
THE UNIVERSITY OF CENTRAL FLORIDA

5: 51–67

UNDERGRADUATE RESEARCH JOURNAL

RESULTS
HR analysis following VP16 drug treatments and
transfection of ISce-I in HR HeLa cells
The treatment of HR HeLa cells with VP16 served as
an initial and essential founding piece of information
for the following results (Figure 5). The positive
control, which includes the transfection of ISce-I with
no subsequent drug treatment, illustrates that the
reporter system is working and shows the potential of
GFP expression. The negative control consists of HR
cells, lacking ISce-I transfection and drug treatment.
These cells provide a background reading of
fluorescence that is ultimately subtracted from the
corresponding ISce-I data points. Although the
anticipated GFP expression for the negative control
should be 0%, the 0.1% GFP finding is likely due to
the nature of the integrated GFP cassettes or
autofluorescence. An autofluorescence control was
not obtained.
The combination of VP16 with the transfection of
ISce-I increased the GFP expression at 72 hours by
1.3% in the 5 µM VP16 range. GFP expression at 72
hours steadily declined with VP16 concentrations
higher than 5 µM (Figure 5). In addition, GFP
expression gradually decreased at 24 and 48 hours
with VP16 concentrations above 5 µM. This is likely
due to toxicity of the VP16 drug (IC50 = 200 µM).
GFP fluorescence in general is low due to the nature
of exposing a poison to cells; the surviving, fluorescing
cells are most likely survivors of the poison exposure.

ISce-I transfection or drug treatment. The results
show that HeLa cells are able to repair the VP16
initiated DSB up to 5 µM concentration (Figure 6).
There is a clear trend towards increasing GFP
expression with increasing concentration of VP16
treatment in both the prolonged and short drug
exposure time frames. During the five day exposure,
there is an increase of GFP beyond the positive
control. The one hour drug treatments also evinced a
trend of increasing GFP expression with increased
dosage of VP16. The data suggest that the presence of
the RY element, the ultra high affinity topoIIα binding
site, is stimulating HR in the GFP reporter through
VP16 drug treatment. In this analysis, cells were
treated at low to high levels of VP16 for a total of five
days or with the same concentration for one hour
followed by five days of recovery. In both cases, it is
clear that VP16 is inducing expression of GFP
through HR at drug concentrations (0.05 – 50 µM).
This indicated that the repair of topoIIα induced
DNA damage can occur through HR. Higher
concentrations of VP16 (> 50 µM) were toxic to the
cells. As a result of this, we decided that a morphological
investigation of the GFP expressed in HR, RY-HR,
and NHEJ HeLa cells was required.

Due to the low percentages and small size of the HR
reporter cassette, a topoIIα targeting sequence was
used. The RY-HR (Figure 4) cassette contains an
ultra high affinity 56 base pair purine rich sequence
for topoIIα[10]. This high affinity topoII binding site,
the RY site, should attract the endogenous topoII and
direct cleavages in this region 5’ of the ISce-I site in
the presence of a drug such as VP16. As a result, the
cellular DNA damage repair system should be
activated with the HR cassette. Two exposure times
of VP16 were allotted for the RY-HR HeLa cells.
One batch of cells was exposed to VP16 for five days.
The second batch was exposed to VP16 for one hour
and then allowed to recover for five days. The positive
control is solely a transfection of ISce-I plasmid while
the negative control represents background GFP
expression in the absence of HR induction through
https://stars.library.ucf.edu/urj/vol5/iss1/6
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Figure 5 - HR in VP16 Treated HR HeLa Cells. HR HeLa cells were transfected with ISce-I and treated with VP16 for 1
hour. A time course for recovery for 72 hours (**p<0.01) was read for GFP expression using FACS analysis. GFP expression is indicative of a HR event. Standard error bars symbolize data range after three replicated trials.
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Figure 6 - HR in VP16 Treated RY-HR HeLa Cells. RY-HR HeLa cells were treated with VP16 for the indicated time frame (5d = 5 days, 1h = 1 hour) at the stated VP16 concentrations. One hour drug treated cells were
incubated for the remaining 5 days in the absence of VP16. All cells were harvested simultaneously for GFP
analysis via FACS (**p<0.4). Standard error bars symbolize data range after three replicated trials.
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Figure 7 - Confocal Microscopy of RY-HR HeLa Cells. RY-HR HeLa cells were seeded over a cover slip and
incubated for 24 hours. Following incubation, 5 µM VP16 (A) and 100 µM VP16 (B) were exposed to the cells for
one hour. The cells were then incubated for two days without VP16 exposure. The cover slips were then removed
and exposed to a PI staining solution for 30 minutes. Confocal microscopy was viewed with fluorescence for
GFP and PI. PI stains the nucleus red and the GFP fluoresces green. GFP expression is indicative of a HR
event. (A) and (B) were captured at 20X magnification.
Confocal Microscopy
Confocal microscopy was performed to examine GFP
expressing cells morphologically (Figure 7 – 8). The
GFP protein appears to be well distributed throughout the cell in the RY-HR cultures treated with VP16
for one hour followed by a 48 hour recovery interval
(Figure 7). At 100 µM VP16, there is an obvious cytotoxic effect on the cells using microscopic observations.
Confocal analyses were performed on the doxycycline
inducible NHEJ and HR reporter cells, to examine
any cytological differences between these two reporter
systems. The NHEJ reporter yielded cells with GFP
distributed throughout the cell (Figure 8). In contrast,
the GFP produced as a result of HR in the HR HeLa
cells without the RY element appears largely in the
nucleus, possibly due to a nuclear localization sequence
on the GFP. GFP is indicative of a HR or NHEJ
event; cells that do not express GFP have not expressed
either of these pathways.

Published by STARS, 2011
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Figure 8 - Confocal Microscopy of HR and NHEJ HeLa Cells. Doxycycline inducible NHEJ and HR HeLa
cell lines were seeded with an inherent slide base. Following one day of incubation, doxycycline was added to the
stated wells. The cells were incubated with the doxycycline for three days. (A) Shows the uninduced HR HeLa
cells at 20X zoom. (B) Shows doxycycline induced HR HeLa cells at 20X zoom. (C) Shows doxycycline induced
NHEJ reporter system integrated HeLa cells at 20X zoom. (D) shows cells from (C) at 100X zoom. The confocal microscope was set to excite solely GFP. GFP expression coincides with the NHEJ or the HR repair pathway
utilization.
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NHEJ Reporter HeLa cells

RY - HR Reporter HeLa Cells

Figure 9 - Cytotoxicity for NHEJ and RY-HR HeLa Cells. Cytotoxicity percentages were calculated for NHEJ
reporter in HeLa cells and RY-HR HeLa cells. Drug treatments lasted for one hour with both VP16 and CPT
(TopoI Poison). The cells were then washed and allotted a recovery interval of 48 hours. Cytotoxicity percentages were calculated using trypan blue exclusion assays.
Published by STARS, 2011
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Figure 10 - HR and NHEJ after VP16 Treatments (A). Illustrates GFP expression from NHEJ reporter cassettes in HeLa cells. (B) Shows GFP expression from RY-HR HeLa cells. Drug treatments lasted for one hour
for both VP16 and CPT (TopoI poison). For the positive controls: ISce-I transfection lasted for four hours and
three day exposure for the DOX inducible NHEJ system. The drug treated cells recovered for three days and
were analyzed for GFP expression using FACS. Transfection efficiency was measured by pEGFP (18%).
https://stars.library.ucf.edu/urj/vol5/iss1/6
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Analysis of Toxicity

DISCUSSION

The results of the trypan blue exclusion assay shows
that with increasing concentration of VP16, there is an
increase in cytotoxicity as expected (Figure 9). VP16 is
a known chemotherapeutic and thus should have a high
toxicity rating as shown in these results. CPT, a highly
specific TopoI poison, shows an increased cytotoxicity
amongst the NHEJ reporter system with concentrations
from 0.5 – 50 µM being toxic. The RY-HR HeLa cells
show increased resistance to CPT. The RY-HR toxicity
data show that VP16 is generally less cytotoxic than
CPT with regard to HR, which indicates that HeLa
cells may be able to repair more efficiently the damage
caused by a topoIIα poison.

This project utilized reporter cassettes to analyze the
repair of DNA damage induced by topoIIαand topoI
poisons. Specific cassettes were employed that report
repair of DSBs by either HR or NHEJ (Figure 4). The
first cassette, in the case of RY-HR cultures, contains
the topoIIα hot spot for the topoIIαpoison and/or an
ISce-I restriction endonuclease cut site. The second
cassette contains the template sequence to repair the
induced DSB in the first cassette. Without drug treatment or pISce-I transfection, GFP is transcribed but
not expressed due to mutations in the first sequence
and a stop codon in the second sequence (Figure 4).
The NHEJ pathway was specifically measured using the
NHEJ reporter (Figure 4). With the NHEJ reporter,
the formation of wild type GFP cannot proceed by HR
due to the lack of a homologous donor sequence. The
expression of GFP from the NHEJ reporter cassette
can thus only result from a NHEJ event.

Analysis of Repair of Topoisomerase I and II DNA Damage
by HR and NHEJ Pathways
There are two major DSB repair pathways in animal
cells: HR and NHEJ. Since we have dedicated reporters for each pathway and given that the drugs are highly
specific for topoI (CPT) or topoII (VP16) mediated
DNA damage, the repair process was evaluated in each
case (Figure 10). In figure 10-A, the NHEJ reporter
system shows there is an increase in susceptibility in
CPT damage and mild reparability in exposure to VP16
with dose dependent decrease in GFP. The positive
control is noticeably elevated in comparison to the
remaining samples. There is a decrease in NHEJ repair
with an increase in VP16 concentration. Figure 10-B
shows the effects of CPT and VP16 on RY-HR HeLa
cells. There is an increase in HR with an increase in
VP16 concentration and the opposite trend with CPT
concentration. GFP expression percentage remains low
in the RY-HR HeLa cells due to the cytotoxicity of the
introduced poisons, and also the expression abilities of
the clones as noted by the positive control. In both instances, 50 µM of CPT or VP16 caused toxicity in the
culture (see also Figure 9). The data points show that
VP16 and CPT HR repair gives a GFP reading close to
that of the positive control, ISce-I transfection. These
trends may mean that HR is the preferred pathway
utilized by HeLa cells to repair from topoIIα and topoI
poison damage.

Published by STARS, 2011

The RY-HR GFP reporter systems indicated that, with
an increase in VP16 concentrations to 5 µM (Figure 10
- B), there is an increase in HR repair. A dose dependent decrease in the NHEJ pathway (Figure 10 – A)
in response to VP16 was also observed. The RY-HR integrated cells showed a dose dependent decrease in HR
treated with the topoI poison, CPT (Figure 10-B). The
DSB initiated by VP16 appears to be repaired through
the high fidelity, error free HR pathway. The high
mitotic activity of cancer cells could make the cell cycle
dependent HR repair pathway preferential compared
to the non-cell cycle dependent NHEJ pathway. Most
healthy cells are in the resting G1/G0 phase and, thus
are not prone to HR DSB repair.
The data in Figure 9 define the toxicity profile of VP16.
The highly specific topoI poison CPT had a higher
toxicity than the VP16. HR may well be the preferred
DSB repair pathway because the cancer cells are constantly dividing and HR is cell cycle specific. Moreover, HR proteins are associated with specific cell cycle
checkpoints, whereas NHEJ is not [14]. Due to the
high mitotic levels of most cancer cells, HR should be
a prominent pathway for break repair. However, not all
cancer cell types follow the HR pathway preferentially.
For example, both normal and malignant urothelial
cells upregulate the NHEJ pathway, while HR is more
dominant in cervical cancer cells [15]. The data and
literature suggest that DSB repair pathways are highly
variable and may well be dependent on tumor tissue
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location. Most importantly, since healthy cells preferentially use NHEJ to repair DSBs, a selective agent for
HR proteins could sensitize cells to anti-cancer treatments while leaving healthy cells relatively unharmed.
One report demonstrated that NHEJ targeting sensitized tumor cells and caused normal cell damage [16].
The targeting of HR could lessen the malevolent impact
of chemotherapy on healthy cells, and thereby target
cancer cells selectively.
These data may illustrate that HeLa cells utilize the HR
pathway over the NHEJ pathway to repair from the exposure of VP16, a topoIIα poison. Future work for this
project includes analyzing, through the same reporter
constructs, the effects of VP16 and CPT drug treatments on cell lines known for specific repair pathway
upregulation. In addition, topoIIβ analysis can be performed based on the two pathways. TopoIIβ has been
found to be a causative enzyme of secondary malignancies in cancer patients treated with topoII poisons.
Finally, knockout or over expression of specific proteins
upregulated in HR such as BRCA1 can be explored for
its effects on both pathways via the GFP system.
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